We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Patterson Cos. (PDCO) Surpasses Market Returns: Some Facts Worth Knowing
Read MoreHide Full Article
Patterson Cos. (PDCO - Free Report) ended the recent trading session at $29.63, demonstrating a +0.73% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.08%. Meanwhile, the Dow experienced a drop of 0.31%, and the technology-dominated Nasdaq saw an increase of 0.02%.
The medical supplies maker's shares have seen an increase of 7.59% over the last month, surpassing the Medical sector's gain of 6.57% and the S&P 500's gain of 3.52%.
The investment community will be closely monitoring the performance of Patterson Cos. in its forthcoming earnings report. The company is expected to report EPS of $0.61, down 1.61% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $1.63 billion, indicating a 2.02% increase compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates project earnings of $2.38 per share and a revenue of $6.62 billion, demonstrating changes of -1.65% and +2.31%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Patterson Cos. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.05% lower. Patterson Cos. is currently a Zacks Rank #4 (Sell).
From a valuation perspective, Patterson Cos. is currently exchanging hands at a Forward P/E ratio of 12.37. This indicates a discount in contrast to its industry's Forward P/E of 21.11.
Also, we should mention that PDCO has a PEG ratio of 1.47. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Medical - Dental Supplies industry was having an average PEG ratio of 1.89.
The Medical - Dental Supplies industry is part of the Medical sector. This group has a Zacks Industry Rank of 205, putting it in the bottom 19% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Patterson Cos. (PDCO) Surpasses Market Returns: Some Facts Worth Knowing
Patterson Cos. (PDCO - Free Report) ended the recent trading session at $29.63, demonstrating a +0.73% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.08%. Meanwhile, the Dow experienced a drop of 0.31%, and the technology-dominated Nasdaq saw an increase of 0.02%.
The medical supplies maker's shares have seen an increase of 7.59% over the last month, surpassing the Medical sector's gain of 6.57% and the S&P 500's gain of 3.52%.
The investment community will be closely monitoring the performance of Patterson Cos. in its forthcoming earnings report. The company is expected to report EPS of $0.61, down 1.61% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $1.63 billion, indicating a 2.02% increase compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates project earnings of $2.38 per share and a revenue of $6.62 billion, demonstrating changes of -1.65% and +2.31%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Patterson Cos. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.05% lower. Patterson Cos. is currently a Zacks Rank #4 (Sell).
From a valuation perspective, Patterson Cos. is currently exchanging hands at a Forward P/E ratio of 12.37. This indicates a discount in contrast to its industry's Forward P/E of 21.11.
Also, we should mention that PDCO has a PEG ratio of 1.47. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Medical - Dental Supplies industry was having an average PEG ratio of 1.89.
The Medical - Dental Supplies industry is part of the Medical sector. This group has a Zacks Industry Rank of 205, putting it in the bottom 19% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.